Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone/naloxone prolonged-release versus oxycodone prolonged-release for opioid-induced constipation in chronic non-malignant pain
2005-002398-57Phase 3Completed
- Sponsor
- Mundipharma Research
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxycodone + naloxone and oxycodone in chronic pain and opioid-induced constipation (OIC) (2 arms), sponsored by Mundipharma Research. Primary endpoint: Bowel Function Index score. Started Aug 2005; status: completed.
02
Drugs
oxycodone + naloxoneoxycodone
03
Conditions
chronic painopioid-induced constipation (OIC)
Beyond the preview
Go deeper on 2005-002398-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002398-57.